Veru (VERU) FCF Payout Ratio (QoQ) (2010 - 2014)
Veru (VERU) FCF Payout Ratio (QoQ) (2010 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 76.89% |
| Sep 30, 2014 | -100.27% |
| Dec 31, 2013 | 187.05% |
| Sep 30, 2013 | -1,183.00% |
| Jun 30, 2013 | -85.47% |
| Mar 31, 2013 | -25.94% |
| Dec 31, 2012 | 133.68% |
| Sep 30, 2012 | -1,082.66% |
| Jun 30, 2012 | 712.09% |
| Mar 31, 2012 | -96.52% |
| Dec 31, 2011 | 171.33% |
| Sep 30, 2011 | -319.40% |
| Dec 31, 2010 | 100.01% |